MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Opus Genetics, Inc. (IRD)

Opus Genetics, Inc. (IRD)

|||

Balance Sheets Overview

Current Ratio
1218.88%
Quick Ratio
1218.88%
Cash Ratio
1167.81%
Debt to Asset Ratio
113.97%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaids and other current asset...
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liabilities
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
88,812
45,091
30,815
32,429
Accounts receivable
1,041
1,995
2,916
3,399
Short-term investments
-
0
0
0
Contract assets and unbilled receivables (note 12)
415
1,170
1,364
1,178
Prepaids and other current assets
2,428
1,788
815
1,433
Total current assets
92,696
50,044
35,910
38,439
Property and equipment, net
172
199
212
226
Restricted cash
100
-
-
-
Total assets
92,968
50,243
36,122
38,665
Warrant liabilities
-
-
21,325
11,800
Accounts payable
1,881
3,293
2,395
1,465
Accrued expenses
5,724
4,488
5,367
6,927
Total current liabilities
7,605
7,781
29,087
20,192
Long-term debt-Nonrelated Party
34,932
-
-
-
Warrant liabilities
62,145
25,985
-
-
Funding agreement, related party
-
1,129
1,068
1,000
Long-term debt-Related Party
1,272
-
-
-
Total liabilities
105,954
34,895
30,155
21,192
Common stock, par value 0.0001 250,000,000 and 125,000,000 shares authorized as of june 30, 2026 and december 31, 2025, respectively 82,647,946 and 69,894,507 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
8
7
6
6
Additional paid-in capital
249,228
203,930
178,027
172,079
Accumulated deficit
-262,222
-188,589
-172,066
-154,612
Total stockholders (deficit) equity
-12,986
15,348
5,967
17,473
Total liabilities, convertible preferred stock and stockholders (deficit) equity
92,968
50,243
36,122
38,665
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$88,812K (173.87%↑ Y/Y)Prepaids and othercurrent assets$2,428K (69.43%↑ Y/Y)Accounts receivable$1,041K (-69.37%↓ Y/Y)Contract assets andunbilled receivables...$415K (-64.77%↓ Y/Y)Total current assets$92,696K (141.15%↑ Y/Y)Property and equipment,net$172K (-23.89%↓ Y/Y)Restricted cash$100K Total assets$92,968K (140.44%↑ Y/Y)Accumulated deficit-$262,222K (-69.60%↓ Y/Y)Total liabilities,convertible preferred stock...$92,968K (140.44%↑ Y/Y)Total stockholders(deficit) equity-$12,986K (-174.32%↓ Y/Y)Additional paid-in capital$249,228K (44.83%↑ Y/Y)Common stock, par value0.0001 250,000,000 and...$8K (33.33%↑ Y/Y)Total liabilities$105,954K (399.97%↑ Y/Y)Warrant liabilities$62,145K (426.65%↑ Y/Y)Long-termdebt-Nonrelated Party$34,932K Total currentliabilities$7,605K (-62.34%↓ Y/Y)Long-term debt-RelatedParty$1,272K Accrued expenses$5,724K (-17.37%↓ Y/Y)Accounts payable$1,881K (28.40%↑ Y/Y)